CymaBay Therapeutics Shares Hit All-Time High on Gilead Deal 

CymaBay Therapeutics shares jumped nearly 25% and hit a new record high in early trading after the clinical-stage biopharmaceutical company agreed to be acquired by Gilead Sciences for $4.3 billion.

Permian Rivals Reach Deal to Create $50 Billion Oil-and-Gas Behemoth 

Diamondback Energy and Autry Stephens's Endeavor announce merger as torrid dealmaking continues in the oil patch.

How an Unremarkable Deal Became a Big Threat to a Small Investment Bank 

History is littered with financial companies that were undone by one bad bet. Investors are worried that B. Riley Financial will be one of them.

Residential Solar Confronts a Critical Year 

High rates and less-generous subsidies have pushed some rooftop solar companies into bankruptcy, and even survivors will have an uphill battle.

Videogame Industry Banks on Distant Coming Attractions 

New Switch console and 'Grand Theft Auto VI' are on the horizon, but big game publishers Electronic Arts and Take-Two are expected to see only modest growth this year.

JB Hi-Fi Half-Year Net Profit Falls, Cuts Dividend 

Australian electronics retailer JB Hi-Fi said its half-year net profit fell by 20%, as consumers pulled back on discretionary spending amid elevated inflation.

Aurizon CEO Says Buyback May be Possible as Outlook for Returns Improves 

Australian rail-freight operator Aurizon Holdings may consider buying back shares, its chief executive said, after flagging a potential increase to shareholder returns next fiscal year.

Why Three Media Giants Made a Hail Mary Bet on Sports Streaming 

Disney, Fox and Warner's venture to bundle live sports content-the latest hit to traditional cable packages-needs to cover high costs and keep leagues on board.

Elon Musk Must Testify in SEC's Twitter Inquiry 

The federal court ruled that Musk's testimony is "relevant and material to the SEC's investigation" and not, as Musk claimed, "unduly burdensome."

Your Medicare Plan Might Not Include as Many Freebies Next Year 

Insurers are likely to favor margins over growth, meaning benefits such as gym memberships might go.

(END) Dow Jones Newswires

02-12-24 1115ET